TerminatedNot Applicable

Af Ablation In Brady-Tachy Syndrome

Stopped: Slow recruitment

France38 participantsStarted 2008-03

Plain-language summary

The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden. The hypothesis of the study is that AF ablation prevents not only from AF episodes recurrence but also from bradycardic episodes.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * paroxystic AF * symptomatic pauses (\>5s at night or 3s during daytime) Exclusion Criteria: * permanent AF * age \> 80 y * pregnant women * minors

What they're measuring

AF burden

Timeframe: 1 year

Trial details

NCT IDNCT00740272

SponsorAbbott Medical Devices

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-12

View on ClinicalTrials.gov More Brady-tachy Syndrome trials